A new ethics of psychiatry: Neuroethics, neuroscience, and technology

Journal of Psychiatric Practice

Volumn 15, Issue 5, 2009, Pages 391-401

  Cheung, Erick H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ethics; Neuro enchancement; Neuroethics; Neuroimaging; Neurotechnology; Psychiatric diagnosis; Psychiatric ethics

Indexed keywords

BIOETHICS; BRAIN FUNCTION; BRAIN RADIOGRAPHY; DIFFUSION TENSOR IMAGING; ELECTROENCEPHALOGRAPHY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MEDICAL ETHICS; NEUROETHICS; NEUROIMAGING; NEURORADIOLOGY; NEUROSCIENCE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHILOSOPHY; POSITRON EMISSION TOMOGRAPHY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TECHNOLOGY;

BRAIN; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; MENTAL DISORDERS; NEUROSCIENCES; PSYCHIATRY; TECHNOLOGY;

EID: 70349738018     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000361279.11210.14     Document Type: Review

References (71)

1. Farah MJ. Emerging ethical issues in neuroscience. Nat Neurosci 2002;5:1123-1129
2. Gazzaniga M. The ethical brain. New York: Harper Collins; 2005.
3. Kennedy D. Just treat, or enhance? Science. 2004;304 (5667):17.
4. Talbot M. Duped: Can brain scans uncover lies? New Yorker July 02, 2007:52-61.
5. Fukushi T, Sakura O, Koizumi H. Ethical considerations of neuroscience research: The perspectives on neuroethics in Japan. Neurosci Res. 2007;57:10-16 (Pubitemid 46084866)
6. Evers K. Neuroethics: A philosophical challenge. Am J Bioeth 2005;5:31-3; discussion W3-4.
7. Akil H, Watson SJ. Science and the future of psychiatry. Arch Gen Psychiatry 2000;57:86-87
8. Kandel ER. A new intellectual framework for psychiatry. Am J Psychiatry 1998;155:457-469
9. Insel TR, Quirion R. Psychiatry as a clinical neuroscience discipline. JAMA 2005;294:2221-2224
10. Rosenhan DL. On being sane in insane places. Science 1973;179:250-258
11. Szasz T. Crazy talk: Thought disorder or psychiatric arrogance? Br J Med Psychol 1993;66 (Pt 1):61-67
12. Reich W. Psychiatric diagnosis as an ethical problem. In: Bloch S, Chodoff P, eds. Psychiatric ethics. second edition. Oxford: Oxford Medical Publications; 1991:101-134
13. Abou-Saleh MT. Neuroimaging in psychiatry: An update. J Psychosom Res 2006;61:289-293
14. Milak MS, Parsey RV, Keilp J, et al. Neuroanatomic correlates of psychopathologic components of major depressive disorder. Arch Gen Psychiatry 2005;62:397-408. (Pubitemid 40471689)
15. Farwell LA, Donchin E. The truth will out: Interrogative polygraphy ("lie detection") with event-related brain potentials. Psychophysiology 1991;28:531-547
16. Kozel FA, Johnson KA, Mu Q, et al. Detecting deception using functional magnetic resonance imaging. Biol Psychiatry 2005;58:605-613 (Pubitemid 41565575)
17. Langleben DD, Loughead JW, Bilker WB, et al. Telling truth from lie in individual subjects with fast event-related fMRI. Hum Brain Mapp 2005;26:262-272
18. Wild J. Brain imaging ready to detect terrorists, say neuroscientists. Nature 2005;437:457. (Pubitemid 41613517)
19. Farah MJ. Neuroethics: The practical and the philosophical. Trends Cogn Sci 2005;9:34-40.
20. McClure SM, Li J, Tomlin D, et al. Neural correlates of behavioral preference for culturally familiar drinks. Neuron 2004;44:379-387 (Pubitemid 39346259)
21. Rosen J. The brain on the stand: How neuroscience is transforming the legal system. New York Times, March 11. 2007 (Available at www.nytimes.com/2007/ 03/11/magazine/11Neurolaw.t.html).
22. Link BG, Phelan JC, Bresnahan M, et al. Public conceptions of mental illness: Labels, causes, dangerousness, and social distance. Am J Public Health 1999;89:1328-1333 (Pubitemid 29404554)
23. Murray CJL, ed. Global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996.
24. Fuchs T. Ethical issues in neuroscience. Curr Opin Psychiatry 2006;19:600-607
25. Nemeroff CB. The burden of severe depression: A review of diagnostic challenges and treatment alternatives. J Psychiatr Res 2007;41:189-206. (Pubitemid 44854991)
26. Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington, DC: American Psychiatric Association; 2000.
27. Skodol AE, Spitzer RL. The development of reliable diagnostic criteria in psychiatry. Annu Rev Med 1982;33: 317-326
28. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry 2003;160:4-12. (Pubitemid 36042419)
29. Robins E, Guze SB. Establishment of diagnostic validity in psychiatric illness: Its application to schizophrenia. Am J Psychiatry 1970;126:983-987
30. Rosman S. Cancer and stigma: Experience of patients with chemotherapy-induced alopecia. Patient Educ Couns 2004;52:333-339 (Pubitemid 38283905)
31. Rothman D. Strangers at the bedside. New York: Aldine de Gruyter; 2003.
32. Link BG, Phelan JC. Stigma and its public health implications. Lancet 2006;367:528-529 (Pubitemid 43208908)
33. Schomerus G, Matschinger H, Angermeyer MC. The stigma of psychiatric treatment and help-seeking intentions for depression. Eur Arch Psychiatry Clin Neurosci 2009; 259:298-306.
34. Wrigley S, Jackson H, Judd F, et al. Role of stigma and attitudes toward help-seeking from a general practitioner for mental health problems in a rural town. Aust N Z J Psychiatry 2005;39:514-521 (Pubitemid 40932630)
35. Angermeyer MC, Matschinger H. Causal beliefs and attitudes to people with schizophrenia. Trend analysis based on data from two population surveys in Germany. Br J Psychiatry 2005;186:331-334 (Pubitemid 40524013)
36. Phelan JC. Genetic bases of mental illness-A cure for stigma? Trends Neurosci 2002;25:430-431
37. Pierre JM. Letter to the editor: Naming names: Auditory hallucinations, inner speech, and source monitoring. Psychol Med 2009;39:1578-9; author reply 1579-1580
38. Lennox BR, Park SB, Medley I, et al. The functional anatomy of auditory hallucinations in schizophrenia. Psychiatry Res 2000;100:13-20. (Pubitemid 30821695)
39. Jones SR, Fernyhough C. Neural correlates of inner speech and auditory verbal hallucinations: A critical review and theoretical integration. Clin Psychol Rev 2007; 27:140-154 (Pubitemid 46123127)
40. Frith CD, Done DJ. Towards a neuropsychology of schizophrenia. Br J Psychiatry 1988;153:437-443
41. McGuire PK, Silbersweig DA, Wright I, et al. The neural correlates of inner speech and auditory verbal imagery in schizophrenia: Relationship to auditory verbal hallucinations. Br J Psychiatry 1996;169:148-159 (Pubitemid 126735156)
42. Whalley HC, Gountouna VE, Hall J, et al. Correlations between fMRI activation and individual psychotic symptoms in un-medicated subjects at high genetic risk of schizophrenia. BMC Psychiatry 2007;7:61 (available at www.biomedcentral.com/1471-244X/7/61).
43. Lui S, Deng W, Huang X, et al. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: An optimized voxel-based morphometry and resting state functional connectivity study. Am J Psychiatry 2009;166:196-205.
44. Beals J, Novins DK, Spicer P, et al. Challenges in operationalizing the DSM-IV clinical significance criterion. Arch Gen Psychiatry 2004;61:1197-1207. (Pubitemid 39602836)
45. First MB, Pincus HA, Levine JB, et al. Clinical utility as a criterion for revising psychiatric diagnoses. Am J Psychiatry 2004;161:946-954 (Pubitemid 38735980)
46. Groeneveld PW, Laufer SB, Garber AM. Technology diffusion, hospital variation, and racial disparities among elderly Medicare beneficiaries: 1989-2000. Med Care 2005;43:320-329
47. Nelson CA. Of eggshells and thin-skulls: A consideration of racism-related mental illness impacting Black women. Int J Law Psychiatry 2006;29:112-136
48. Andreasen NC. Schizophrenia: The fundamental questions. Brain Res Brain Res Rev 2000;31:106-112
49. Glannon W. Neuroethics. Bioethics 2006;20:37-52.
50. McGorry PD,Yung AR. Early intervention in psychosis: An overdue reform. Aust N Z J Psychiatry 2003;37:393-398 (Pubitemid 37121571)
51. Yung AR, Killackey E, Hetrick SE, et al. The prevention of schizophrenia. Int Rev Psychiatry 2007;19:633-646
52. Yung AR, McGorry PD. Prediction of psychosis: Setting the stage. Br J Psychiatry Suppl 2007;51:s1-s8.
53. Gosden R. Prepsychotic treatment for schizophrenia: Preventive medicine, social control, or drug marketing strategy? Ethical Hum Sci Serv 1999;1:165-177
54. Jackson GE. The dilemma of early intervention: Some problems in mental health screening and labeling. Ethical Hum Sci Serv 2003;5:35-40.
55. Farah MJ, Illes J, Cook-Deegan R, et al. Neurocognitive enhancement: What can we do and what should we do? Nat Rev Neurosci 2004;5:421-425
56. Harmer CJ, Shelley NC, Cowen PJ, et al. Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 2004; 161:1256-1263
57. Harmer CJ, Bhagwagar Z, Perrett DI, et al. Acute SSRI administration affects the processing of social cues in healthy volunteers. Neuropsychopharmacology 2003;28: 148-152
58. Norbury R, Mackay CE, Cowen PJ, et al. The effects of reboxetine on emotional processing in healthy volunteers: An fMRI study. Mol Psychiatry 2008;13:1011-1020
59. Murphy SE, Yiend J, Lester KJ, et al. Short-term serotonergic but not noradrenergic antidepressant administration reduces attentional vigilance to threat in healthy volunteers. Int J Neuropsychopharmacol 2009;12:169-179
60. Elliott R, Sahakian BJ, Matthews K, et al. Effects of methylphenidate on spatial working memory and planning in healthy young adults. Psychopharmacology (Berl) 1997;131:196-206. (Pubitemid 27261609)
61. DeSantis AD, Webb EM, Noar SM. Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. J Am Coll Health 2008;57: 315-324
62. Brown P. Ethical aspects of drug treatment. In: Bloch S, Chodoff P, eds. Psychiatric ethics. second edition. Oxford: Oxford Medical Publications; 1991:167-184
63. Loo CK, Mitchell PB. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 2005;88:255-267 (Pubitemid 41447523)
64. George MS, Nahas Z, Borckardt JJ, et al. Brain stimulation for the treatment of psychiatric disorders. Curr Opin Psychiatry 2007;20:250-4; discussion 247-249 (Pubitemid 46591335)
65. Daskalakis ZJ, Levinson AJ, Fitzgerald PB. Repetitive transcranial magnetic stimulation for major depressive disorder: A review. Can J Psychiatry 2008;53:555-566
66. Avery DH, Isenberg KE, Sampson SM, et al. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: Clinical response in an open-label extension trial. J Clin Psychiatry 2008;69:441-451
67. Fitzgerald PB, Benitez J, de Castella A, et al. A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression. Am J Psychiatry 2006;163:88-94. (Pubitemid 43050108)
68. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron 2005; 45:651-660 (Pubitemid 40320700)
69. Merskey H. Ethical aspects of the physical manipulation of the brain. In: Bloch S, Chodoff P, eds. Psychiatric ethics. second edition. Oxford: Oxford Medical Publications; 1991: 185-214.
70. Montgomery EB, Gale JT. Mechanisms of action of deep brain stimulation (DBS). Neurosci Biobehav Rev 2008;32: 388-407. (Pubitemid 351181336)
71. Hardesty DE, Sackeim HA. Deep brain stimulation in movement and psychiatric disorders. Biol Psychiatry 2007;61:831-835 (Pubitemid 46412276)